Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03131206
Title A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

thyroid gland cancer

lung non-small cell carcinoma

Therapies

Alectinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST